Journals / Türk Biyokimya Dergisi / 2018 / Cilt: 43 - Sayı: 2

Synthesis and evaluation of new benzimidazole derivatives with hydrazone moiety as anticancer agents

Hidrazon yapısı içeren yeni benzimidazol türevlerinin sentezi ve antikanser ajan olarak değerlendirilmesi

Pages
151–158
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the substituenteffect on cytotoxic activity, compound 3e bearing2-methylthiophene has attracted attention with its higheranticancer activities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Cancer is one of the leading causes of deaththroughout the world.
📊
Key Findings & Data:From this pointof view, in the present study benzimidazole-hydrazonederivatives were synthesized by aiming at the identificationof new chemical entities as potent anticancer agents.Material and methods: A series of 12 new compounds of4-(5(6)-substituted-1H-benzimidazol-2-yl)-N′thiophen/furan-2-yl-methylene) benzohydrazide derivatives weresynthesized.
💡
Conclusion & Impact:Considering the substituenteffect on cytotoxic activity, compound 3e bearing2-methylthiophene has attracted attention with its higheranticancer activities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Cancer is one of the leading causes of deaththroughout the world. Current therapy options sufferfrom the major limitations of side effects and drug resistance.Thus, continuing search for newer and safer anticancerdrugs remains critically important. From this pointof view, in the present study benzimidazole-hydrazonederivatives were synthesized by aiming at the identificationof new chemical entities as potent anticancer agents.Material and methods: A series of 12 new compounds of4-(5(6)-substituted-1H-benzimidazol-2-yl)-N′thiophen/furan-2-yl-methylene) benzohydrazide derivatives weresynthesized. The structures of the obtained compoundswere elucidated using by IR, 1H NMR, 13C NMR, mass spectroscopyand elemental analyses. In vitro cytotoxic activityof the compounds against A549, MCF-7 and NIH/3T3 celllines was evaluated by MTT assay.Results: Among the tested compounds, compound 3eshowed higher cytotoxicity against MCF-7 human breastcancer cells when compared with cisplatin. Also, it haslower cytotoxicty against healthy cell line, NIH/3T3.Conclusions: It was determined that compound 3eshowed inhibition towards MCF-7. Considering the substituenteffect on cytotoxic activity, compound 3e bearing2-methylthiophene has attracted attention with its higheranticancer activities.

Özet

Amaç: Kanser, dünyadaki ölümlerin önde gelen nedenlerinden biridir. Günümüzdeki tedavi seçenekleri yan etki ve ilaç direnci gibi önemli kısıtlılıklara sahiptir. Bu nedenle daha yeni ve güvenli antikanser ilaçlar için devam eden araştırmalarının kritik önemi vardır. Bu noktadan hareketle, bu çalışmada yeni kimyasal yapıların güçlü antikanser yapılar olarak tanımlanmasını amaçlayarak benzimidazol- hidrazon türevlerini sentezledik. Gereç ve Yöntem: 12 yeni bileşikten oluşan 4-(5(6)-Sübstitüe- 1H-benzimidazol-2-il)-N′(tiyofen/furan-2-il-metilen) benzohidrazid serisi sentezlenmiştir. Elde edilen bileşiklerin yapıları FT-IR, 1H-NMR, 13C-NMR, kütle spektroskopisi verileri ve elementel analiz kullanılarak aydınlatılmıştır. Bileşiklerin in vitro sitotoksik aktivitesi MTT metodu kullanılarak değerlendirilmiştir. Bulgular: Test edilen bileşikler arasında bileşik 3e, sisplatin ile karşılaştırıldığında MCF-7 insan meme kanser hücrelerine karşı sitotoksik aktivite göstermiştir.Sonuç: Bileşik 3e’nin MCF-7’ye karşı selektif sitotoksiste gösterdiği tespit edilmiştir. Kimyasal yapıdaki değişken grupların sitotoksik aktivite üzerine etkileri değerlendirildiğinde, 2-metiltiyofen yapısı içeren bileşik 3e, gösterdiği yüksek aktivite ile dikkat çekmektedir.

🔖

Cite This Article

SAĞLIK, B. N., ATLI, Ö., ÖZKAY, Y., ÇEVİK, U. A., ARDIÇ, C. M. (2022). Synthesis and evaluation of new benzimidazole derivatives with hydrazone moiety as anticancer agents. Türk Biyokimya Dergisi, Cilt: 43 - Sayı: 2, 151–158. https://ajindex.com/articles/620936

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Rashid M, Husain A, Mishra R, Karim S, Khan S, Ahmad M, et al. Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents. Arab J Chem 2015 (in press). http:// dx.doi.org/10.1016/j.arabjc.2015.08.019
  2. Kumar GJ, Kumar SN. Synthesis and characterization of new s-triazine bearing benzimidazole and benzothiazole derivatives as anticancer agents. Med Chem Res 2015;24:3991–4001
  3. Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R. Design, synthesis and biological evaluation of 1,3-diphenyl- 1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Eur J Med Chem 2015;101:790–805
  4. Babu PK, Ramadevi B, Poornachandra Y, Kumar CG. Synthesis, antimicrobial, and anticancer evaluation of novel 2-(3-methylindolyl) benzimidazole derivatives. Med Chem Res 2014;23(9):3970–8
  5. Singla P, Luxami V, Singh R, Tandon V, Paul K. Novel pyrazolo [3, 4-d] pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies. Eur J Med Chem 2017;126:24–35
  6. Akhtar J, Khan AA, Ali Z, Haider R, Yar MS. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Eur J Med Chem 2017;125:143–89
  7. Nofal ZM, Soliman EA, El-Karim A, Somaia S, El-Zahar MI, Srour AM, et al. Synthesis of some new benzimidazole–thiazole derivatives as anticancer agents. J Heterocycl Chem 2014;51: 1797–806
  8. Yu X, Shi L, Ke S. Acylhydrazone derivatives as potential anticancer agents: synthesis, bio-evaluation and mechanism of action. Bioorg Med Chem Lett 2015;25:5772–6
  9. Wu LT, Jiang Z, Shen JJ, Yi H, Zhan YC, Sha MQ, et al. Design, synthesis and biological evaluation of novel benzimidazole- 2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents. Eur J Med Chem 2016;114:328–36
  10. Shao KP, Zhang XY, Chen PJ, Xue DQ, He P, Ma LY, et al. Synthesis and biological evaluation of novel pyrimidine–benzimidazol hybrids as potential anticancer agents. Bioorg Med Chem Lett 2014;24:3877–81
  11. Husain A, Rashid M, Shaharyar M, Siddiqui AA, Mishra R. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents. Eur J Med Chem 2013;62:785–98
  12. Palma E, Marques F, Gano L, Oliveira MC,